Related Experiment Video
Updated: Aug 19, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Hypertension and vascular disease
1Department of Medicine, University of Melbourne, St. Vincent's Hospital, Victoria, Australia.
Insights
Antihypertensive drug treatment shifts hypertension complications from heart failure to heart attack and stroke. Current evidence does not show blood pressure reduction prevents atherosclerosis, suggesting cholesterol may be the primary issue.
Area of Science:
- Cardiovascular Medicine
- Hypertension Research
- Atherosclerosis Studies
Background:
- Antihypertensive drug treatment has significantly altered the clinical presentation of hypertension.
- Previously, major complications included congestive heart failure, cerebral hemorrhage, and renal failure.
- In treated patients, myocardial infarction and thrombotic stroke are now prominent concerns.
Purpose of the Study:
- To evaluate the impact of antihypertensive drug treatment on the natural history and complications of hypertension.
- To assess whether reducing blood pressure effectively mitigates atherosclerotic complications.
- To explore the relationship between hypertension, atherosclerosis, and lipoprotein metabolism.
Main Methods:
- Review of major therapeutic trials in hypertension.
- Analysis of experimental animal data on hypertension and atheromatous lesions.
- Examination of the relationship between serum cholesterol levels and hypertension.
Main Results:
- Major therapeutic trials have not demonstrated that blood pressure reduction prevents atherosclerotic complications.
- Hypertension may exacerbate atheromatous lesions in both experimental animals and humans.
- Atherosclerosis is strongly linked to lipoprotein metabolism disturbances.
Conclusions:
- The primary lesion in hypertensive patients may be atherosclerosis, with hypertension as a secondary complication.
- Elevated serum cholesterol is a key factor in atherosclerosis, potentially more so than hypertension itself.
- Current treatments may shift the manifestation of cardiovascular risk in hypertensive individuals rather than eliminate it.
Abstract:
The use of antihypertensive drug treatment has altered the natural history of hypertension. Whereas congestive heart failure, cerebral hemorrhage, and renal failure were the major complications of untreated severe hypertension, myocardial infarction and thrombotic stroke have emerged as major problems in treated hypertensive patients. None of the major therapeutic trials in hypertension have provided evidence that reducing blood pressure reduces the risk of atherosclerotic complications of hypertension. Hypertension certainly aggravates the severity of atheromatous lesions in experimental animals, and may do so in humans. However, atherosclerosis is more closely related to disturbances in lipoprotein metabolism than to other factors. The common finding that serum cholesterol is raised in hypertensive patients may be due to atherosclerosis being the primary lesion, and hypertension a secondary complication rather than hypertension being the primary lesion.
More Related Videos
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
08:41Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Cardiovascular Drugs: Classification based on Therapeutic Indications
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management